PUBLIC CONTRACT · 2018

06/01405.11/2018 - Aq. do medicamento “Sofosbuvir 400 mg + Velpatasvir 100 mg Comp” e “Glecaprevir 100 mg + Pibrentasvir 40 mg Comp” – Hepatite C Crónica

Contract value: €230,919.15
Signed on: 14 June 2018
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 4551726

PUBLISHED SUBJECT

Aquisição dos medicamentos “Sofosbuvir 400 mg + Velpatasvir 100 mg Comp” e “Glecaprevir 100 mg + Pibrentasvir 40 mg Comp” – Hepatite C Crónica (AQ 2017/067)

Parties involved

Contracting body: Centro Hospitalar de Entre o Douro e Vouga, E.P.E.
Awardee: Gilead Sciences, Lda.
Place of performance: Portugal, Aveiro, Santa Maria da Feira
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: Gilead Sciences, Lda. · Tax ID 503604704
Bidder: ABBVIE, Lda. · Tax ID 510229050

Values and timeline

Contract price: €230,919.15
Procedure base price: €0.00
Total effective price: Not reported on Portal BASE
Publication date: 14 June 2018
Award date: 6 June 2018
Signing date: 14 June 2018
Performance period: 200 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Not stated
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL 18/2008)
Framework agreement: CP 2017/67 - Medicamentos para a Hepatite C crónica
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 3393422

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts